253 related articles for article (PubMed ID: 9233698)
1. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
Schuler W; Sedrani R; Cottens S; Häberlin B; Schulz M; Schuurman HJ; Zenke G; Zerwes HG; Schreier MH
Transplantation; 1997 Jul; 64(1):36-42. PubMed ID: 9233698
[TBL] [Abstract][Full Text] [Related]
2. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.
Schuurman HJ; Cottens S; Fuchs S; Joergensen J; Meerloo T; Sedrani R; Tanner M; Zenke G; Schuler W
Transplantation; 1997 Jul; 64(1):32-5. PubMed ID: 9233697
[TBL] [Abstract][Full Text] [Related]
3. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts.
Viklický O; Zou H; Müller V; Lacha J; Szabó A; Heemann U
Transplantation; 2000 Feb; 69(4):497-502. PubMed ID: 10708101
[TBL] [Abstract][Full Text] [Related]
4. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
Hausen B; Boeke K; Berry GJ; Segarra IT; Christians U; Morris RE
J Heart Lung Transplant; 1999 Feb; 18(2):150-9. PubMed ID: 10194039
[TBL] [Abstract][Full Text] [Related]
5. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
[TBL] [Abstract][Full Text] [Related]
6. Early clinical experience with a novel rapamycin derivative.
Nashan B
Ther Drug Monit; 2002 Feb; 24(1):53-8. PubMed ID: 11805723
[TBL] [Abstract][Full Text] [Related]
7. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
9. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
[TBL] [Abstract][Full Text] [Related]
10. Chemical modification of rapamycin: the discovery of SDZ RAD.
Sedrani R; Cottens S; Kallen J; Schuler W
Transplant Proc; 1998 Aug; 30(5):2192-4. PubMed ID: 9723437
[No Abstract] [Full Text] [Related]
11. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.
Hausen B; Boeke K; Berry GJ; Christians U; Schüler W; Morris RE
Ann Thorac Surg; 2000 Mar; 69(3):904-9. PubMed ID: 10750781
[TBL] [Abstract][Full Text] [Related]
12. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
Hausen B; Boeke K; Berry GJ; Segarra I; Benet LZ; Christians U; Morris RE
Transplantation; 1999 Apr; 67(7):956-62. PubMed ID: 10221478
[TBL] [Abstract][Full Text] [Related]
13. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
Böhler T; Waiser J; Budde K; Lichter S; Jauho A; Fritsche L; Korn A; Neumayer HH
Transplant Proc; 1998 Aug; 30(5):2195-7. PubMed ID: 9723438
[No Abstract] [Full Text] [Related]
14. Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide.
Lhoëst GJ; Gougnard TY; Verbeeck RK; Maton N; Dehoux JP; Wallemacq P; Schüler W; Latinne D
J Mass Spectrom; 2000 Mar; 35(3):454-60. PubMed ID: 10767777
[TBL] [Abstract][Full Text] [Related]
15. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation.
Schuurman HJ; Schuler W; Ringers J; Jonker M
Transplant Proc; 1998 Aug; 30(5):2198-9. PubMed ID: 9723439
[No Abstract] [Full Text] [Related]
16. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.
Serkova N; Litt L; Leibfritz D; Hausen B; Morris RE; James TL; Benet LZ; Christians U
Br J Pharmacol; 2000 Feb; 129(3):485-92. PubMed ID: 10711346
[TBL] [Abstract][Full Text] [Related]
17. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin.
Crowe A; Lemaire M
Pharm Res; 1998 Nov; 15(11):1666-72. PubMed ID: 9833985
[TBL] [Abstract][Full Text] [Related]
19. The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats.
Simler NR; Howell DC; Marshall RP; Goldsack NR; Hasleton PS; Laurent GJ; Chambers RC; Egan JJ
Eur Respir J; 2002 Jun; 19(6):1124-7. PubMed ID: 12108867
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
Kirchner GI; Winkler M; Mueller L; Vidal C; Jacobsen W; Franzke A; Wagner S; Blick S; Manns MP; Sewing KF
Br J Clin Pharmacol; 2000 Nov; 50(5):449-54. PubMed ID: 11069439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
